Effect of oral contraceptives on risk of cervical cancer

Journal of the Medical Association of Thailand

Volumn 91, Issue 1, 2008, Pages 7-12

  Vanakankovit, Natthakan ^a   Taneepanichskul, Surasak ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Cervical cancer; Oral contraceptives

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; RISK ASSESSMENT; RISK FACTOR; STRUCTURED QUESTIONNAIRE; THAILAND; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; FEMALE; HEALTH SURVEYS; HUMANS; INTERVIEWS AS TOPIC; MIDDLE AGED; ODDS RATIO; RISK FACTORS; THAILAND; TIME FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 39349110746     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Delgado-Rodriguez M, Sillero-Arenas M, Martin-Moreno JM, Galvez-Vargas R. Oral contraceptives and cancer of the cervix uteri. A meta-analysis. Acta Obstet Gynecol Scand 1992; 71: 368-76.
2. Munoz N, Bosch FX, de Sanjose S, Tafur L, Izarzugaza I, Gili M, et al. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 1992; 52: 743-9.
3. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-9.
4. International Agency for Research of Cancer. IARC monographs on the evaluation of the carcinogenic risk to humans. Vol. 72. Hormonal contraception and post-menopausal hormonal therapy. Lyon: IARC; 1999.
5. Ministry of Public Health. Cancer in Thailand. Vol. III. Nonthaburi: Ministry of Public Health; 2003
6. Beral V, Hermon C, Kay C, Hannaford P, Darby S, Reeves G. Mortality associated with oral contraceptive use: 25-year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study. BMJ 1999; 318: 96-100.
7. Swan SH, Petitti DB. A review of problems of bias and confounding in epidemiologic studies of cervical neoplasia and oral contraceptive use. Am J Epidemiol 1982; 115: 10-8.
8. Moreno V, Bosch FX, Munoz N, Meijer CJ, Shah KV, Walboomers JM, et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Lancet 2002; 359: 1085-92.
9. Chichareon S, Herrero R, Munoz N, Bosch FX, Jacobs MV, Deacon J, et al. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 1998; 90: 50-7.